Rakon

No forward guidance, order book, or quantitative target was disclosed in the extracted release. On shape, HY22 was 49.7% of FY22 revenue but 57.2% of FY22 NPAT, so the prior year was modestly second-half weighted on revenue but first-half weighted on profit. Annualising HY23 revenue gives ~NZ$174.3m, only marginally above FY22's NZ$172.0m — so the release does not support a step-change in the top-line trajectory. It does support a stable-to-slightly-improving underlying earnings base on a pre-tax view, but it does not support confidence in cash delivery without a second-half inventory unwind.

• Is the NZ$28.5m inventory build demand-led pre-positioning, a supply-chain buffer, or slow-moving stock that will need to be written down?
• What drove the 97bps gross margin compression — input costs, product mix, or pricing?
• Why did capex step up to 10.8% of revenue, and is this a new run-rate tied to the India facility or a one-off?
• What is the dividend position for the period? The extraction flags an "Interim/Final Dividend" line but no amount is captured.
• How much of the NZ$6.3m FX uplift to cash flatters the reported cash position, given disclosed multi-currency operations?

This briefing cannot assess customer concentration, forward order book, or segment profitability, as none of these were disclosed in the supplied excerpts.